PATENT CLAIM ANALYSIS

Application Number: 15972996
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["514", "064000"]

Abstract:
Compounds according to Formula I and Formula II are potent inhibitors of Arginase I and II activity: where R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , D, M, X, and Y are defined as set forth in the specification. The invention also provides pharmaceutical compositions of the compounds and methods of their use for treating or preventing a disease or a condition associated with arginase activity.

Claim (Index 45):
The method according to  claim 28 , wherein the disease or condition is a gastrointestinal disorder.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 93.0
- Lexical Diversity: 1.56897
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14471244', '15207902', '13276806', '14614115', '15540888']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8221005584710167
- 35 USC 102 Novelty (BERT): 0.544774316403931
- Combined Prediction Score: 0.7943679342643082
- Mean Citation Score: 379.857086
- Max Citation Score: 434.2485
- Similarity Product: 237.26595651054387

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test